↓ Skip to main content

Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies

Overview of attention for article published in Cancer Immunology, Immunotherapy, January 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
49 Mendeley
Title
Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies
Published in
Cancer Immunology, Immunotherapy, January 2004
DOI 10.1007/s00262-003-0457-9
Pubmed ID
Authors

Pamela J. Russell, Dean Hewish, Teresa Carter, Katy Sterling-Levis, Kim Ow, Meghan Hattarki, Larissa Doughty, Robin Guthrie, Deborah Shapira, Peter L Molloy, Jerome A. Werkmeister, Alexander A. Kortt

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 2%
Unknown 48 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 20%
Student > Master 9 18%
Student > Ph. D. Student 8 16%
Student > Bachelor 4 8%
Professor 2 4%
Other 5 10%
Unknown 11 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 24%
Biochemistry, Genetics and Molecular Biology 11 22%
Pharmacology, Toxicology and Pharmaceutical Science 6 12%
Chemistry 5 10%
Computer Science 1 2%
Other 2 4%
Unknown 12 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2016.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from Cancer Immunology, Immunotherapy
#568
of 2,982 outputs
Outputs of similar age
#17,284
of 146,193 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#3
of 25 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,982 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,193 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.